{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Los Angeles",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "77757",
      "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical",
      "address_1": "1990 Westwood Blvd Ste 135",
      "address_2": "N/A",
      "postal_code": "90025-4650",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "There were only one customer in California",
      "recall_number": "D-1040-2017",
      "product_description": "Testosterone Cypionate + Progesterone, 200 mg/ 2.5 mg/mL  ,10 mL amber glass vials, Rx Only, Compounded by AXIA Pharmaceutical, Los Angeles, CA 90025",
      "product_quantity": "120 vials",
      "reason_for_recall": "CGMP Deviations",
      "recall_initiation_date": "20170712",
      "center_classification_date": "20170731",
      "termination_date": "20190114",
      "report_date": "20170809",
      "code_info": "Lot # 03022017+44906; BUD 08/29/17"
    }
  ]
}